We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+17.13%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$31.9B
AUM Growth
+$4.19B
Cap. Flow
+$23.1M
Cap. Flow %
0.07%
Top 10 Hldgs %
18.87%
Holding
1,397
New
111
Increased
494
Reduced
445
Closed
146

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$83.9M
2
QDEL icon
QuidelOrtho
QDEL
+$75.7M
3
GXC icon
State Street SPDR S&P China ETF
GXC
+$73.7M
4
TSLA icon
Tesla
TSLA
+$58.1M
5
MSFT icon
Microsoft
MSFT
+$48.7M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$149M
2
HON icon
Honeywell
HON
+$72.2M
3
IBM icon
IBM
IBM
+$66M
4
INTC icon
Intel
INTC
+$63.3M
5
LMND icon
Lemonade
LMND
+$56M

Sector Composition

Rank Sector Weight
1 Technology 31.17%
2 Healthcare 17.83%
3 Consumer Discretionary 11.58%
4 Financials 10.55%
5 Industrials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIG
676
DELISTED
Big Lots, Inc.
BIG
$4.8M 0.02%
111,800
ROL icon
677
Rollins
ROL
$16.2B
$4.79M 0.02%
122,566
-1,051
-0.9% -$40.7K
MD icon
678
Pediatrix Medical
MD
$2.17B
$4.79M 0.02%
195,000
COLM icon
679
Columbia Sportswear
COLM
$2.89B
$4.77M 0.02%
54,596
+2,334
+4% +$203K
WKC icon
680
World Kinect Corp
WKC
$1.82B
$4.76M 0.01%
152,710
+66,010
+76% +$1.76M
STRA icon
681
Strategic Education
STRA
$1.85B
$4.7M 0.01%
49,305
+5,322
+12% +$494K
YMAB
682
DELISTED
Y-mAbs Therapeutics
YMAB
$4.68M 0.01%
94,615
-94,582
-50% -$4.38M
PCTY icon
683
Paylocity
PCTY
$7.81B
$4.67M 0.01%
+22,700
New +$4.37M
BERY
684
DELISTED
Berry Global Group, Inc.
BERY
$4.62M 0.01%
+89,625
New +$4.28M
BE icon
685
Bloom Energy
BE
$76.4B
$4.62M 0.01%
+161,125
New +$3.44M
ICFI icon
686
ICF International
ICFI
$1.59B
$4.62M 0.01%
62,100
OSIS icon
687
OSI Systems
OSIS
$3.23B
$4.61M 0.01%
49,400
-900
-2% -$76.9K
ACC
688
DELISTED
American Campus Communities, Inc.
ACC
$4.53M 0.01%
105,883
-65,700
-38% -$2.62M
MTH icon
689
Meritage Homes
MTH
$4.29B
$4.53M 0.01%
109,298
-22,400
-17% -$1.06M
RLJ icon
690
RLJ Lodging Trust
RLJ
$1.67B
$4.5M 0.01%
317,821
-8,300
-3% -$93.1K
EGO icon
691
Eldorado Gold
EGO
$10.5B
$4.46M 0.01%
335,700
CMPR icon
692
Cimpress
CMPR
$2.03B
$4.45M 0.01%
50,677
-887
-2% -$76.2K
ADEA icon
693
Adeia
ADEA
$2.75B
$4.43M 0.01%
801,360
PAG icon
694
Penske Automotive Group
PAG
$14.2B
$4.43M 0.01%
74,600
-8,800
-11% -$496K
COGT icon
695
Cogent Biosciences
COGT
$5.68B
$4.39M 0.01%
+390,659
New +$4.29M
PNW icon
696
Pinnacle West Capital
PNW
$11.5B
$4.34M 0.01%
54,247
+1,300
+2% +$107K
BYND icon
697
Beyond Meat
BYND
$172M
$4.33M 0.01%
1,156
+287
+33% +$1.3M
CATM
698
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$4.29M 0.01%
121,600
+15,000
+14% +$375K
SPWR
699
DELISTED
SunPower Corporation Common Stock
SPWR
$4.29M 0.01%
+167,271
New +$3.38M
CWEN icon
700
Clearway Energy Class C
CWEN
$6.14B
$4.25M 0.01%
+132,974
New +$3.99M

Similar funds

Axa's Q4 2020 Portfolio in Review

As of Q4 2020, Axa held 1,397 positions worth $31.9B, up 15% from $27.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q4 2020 filing shows 111 new, 494 increased, 445 reduced and 146 closed positions. Its largest new stake was State Street SPDR S&P China ETF: 580,524 shares worth $75.6M. The largest sale was Linde, an estimated $149M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q4 2020 buy was State Street SPDR S&P China ETF: 580,524 shares worth $75.6M.
  • Axa added most to Amazon in Q4 2020, an estimated $83.9M increase.
  • Axa's biggest Q4 2020 reduction was Linde, cutting an estimated $149M.
  • Axa fully exited Jumia Technologies in Q4 2020, selling an estimated $42.2M.
  • Axa's ten largest holdings make up 19% of its $31.9B portfolio in Q4 2020.
  • Axa opened 111 new positions and closed 146 in Q4 2020.
  • Axa's portfolio value rose 15% quarter-over-quarter to $31.9B.

Based on Axa's 13F filing for Q4 2020, filed 12 Feb 2021.